BMJ 1999;319:589-590 ( 4 September )

Editorials

British guidelines on managing hypertension

Provide evidence, progress, and an occasional missed opportunity

Education and debate p   630

The first 150 words of the full text of this article appear below.

This issue of the BMJ includes a summary of the new British Hypertension Society guidelines for managing hypertension.¹ Recently, one of the authors of these guidelines commented on the strengths of the fifth and sixth reports of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC): "The JNC reports score highly on two countsthey took note of important new evidence, and unlike the others, delivered a clear message."² The same can be said of this version of the British guidelines, which represent an outstanding summary of the existing evidence about the diagnosis and treatment of hypertension. In contrast to the World Health Organisation-International Society of Hypertension³ and the Joint National Committee VI guidelines,⁴ the brevity of this version will make the British Hypertension Society guidelines especially useful to clinicians.

The authors aimed to produce an evidence based document, and in the full version . . . [Full text of this article]

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    StumbleUpon    Technorati    What's this?

Relevant Articles

Management of hypertension

John Wilding, Gareth Williams, Garfield Drummond, Tom Marshall, Andrew Rouse, John Eisenberg, Angela Hey, Tahseen A Chowdhury, Hogne Sandvik, Michael Stewart, N J Sharvill, Bruce M Psaty, Curt D Furberg, Lawrence E Ramsay, Bryan Williams, John F Potter, G Dennis Johnston, Graham A MacGregor, Lucilla Poston, Neil R Poulter, and Gavin Russell
BMJ 2000 320: 576. [Extract] [Full Text] [PDF]

British Hypertension Society guidelines for hypertension management 1999: summary

Lawrence E Ramsay, Bryan Williams, G Dennis Johnston, Graham A MacGregor, Lucilla Poston, John F Potter, Neil R Poulter, and Gavin Russell
BMJ 1999 319: 630-635. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

• Psaty, B. M. (2009). Conflict of Interest, Disclosure, and Trial Reports. JAMA 301: 1477-1479 [Full text]  
• Sniderman, A. D., Furberg, C. D. (2009). Why Guideline-Making Requires Reform. JAMA 301: 429-431 [Full text]  
• Burgers, J. S., Bailey, J. V., Klazinga, N. S., Van der Bij, A. K., Grol, R., Feder, G. (2002). Inside Guidelines: Comparative analysis of recommendations and evidence in diabetes guidelines from 13 countries. Diabetes Care 25: 1933-1939 [Abstract] [Full text]  
• Psaty, B. M, Pahor, M. (2000). Doxazosin was associated with more stroke and cardiovascular disease events than chlorthalidone in high risk hypertension. Evid. Based Med. 5: 172-172 [Full text]  
• Wilding, J., Williams, G., Drummond, G., Marshall, T., Rouse, A., Eisenberg, J., Hey, A., Chowdhury, T. A, Sandvik, H., Stewart, M., Sharvill, N J, Psaty, B. M, Furberg, C. D, Ramsay, L. E, Williams, B., Potter, J. F, Johnston, G D., MacGregor, G. A, Poston, L., Poulter, N. R, Russell, G. (2000). Management of hypertension. BMJ 320: 576-576 [Full text]  

Rapid Responses:

Read all Rapid Responses

What about non-medical remedies first?

Angela Hey
bmj.com, 8 Sep 1999 [Full text]

hypertension is a neceesity and not to be reduced

Fazlur Rahman
bmj.com, 14 Sep 1999 [Full text]

Hypertension guidelines

N J Sharvill
bmj.com, 15 Sep 1999 [Full text]

Mortality preferred to ''''major disease end points''''

Michael Stewart
bmj.com, 21 Sep 1999 [Full text]

Online poll

Find out more >>